COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury

Light chain (AL) amyloidosis is a potentially fatal disease of monoclonal plasma cells that leads to accumulation of light chain amyloid fibrils, organ damage, and the manifestations of clinical disease. Meanwhile, coronavirus disease 2019 (COVID-19) is a disease caused by infection with the severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Crees, Zachary D., Stockerl-Goldstein, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783834/
https://www.ncbi.nlm.nih.gov/pubmed/35081378
http://dx.doi.org/10.1016/j.amjmed.2022.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783834/
https://www.ncbi.nlm.nih.gov/pubmed/35081378
http://dx.doi.org/10.1016/j.amjmed.2022.01.005

Ejemplares similares